| scholarly article | Q13442814 |
| P2093 | author name string | Choong-Chin Liew | |
| Victor J Dzau | |||
| Paul D Allen | |||
| Dimitrios Stamatiou | |||
| J David Barrans | |||
| P2860 | cites work | Genomic circuits and the integrative biology of cardiac diseases | Q34042375 |
| Genomics and the pathophysiology of heart failure | Q34221034 | ||
| MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure | Q34416947 | ||
| Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure | Q34978011 | ||
| Construction of a human heart cDNA library and identification of cardiovascular based genes (CVBest). | Q36879935 | ||
| Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene | Q40893835 | ||
| The role of cytoskeletal proteins in cardiomyopathies | Q41713568 | ||
| Cloning and expression of a cDNA encoding human inositol 1,4,5-trisphosphate 3-kinase C. | Q41858547 | ||
| Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. | Q52188555 | ||
| Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays | Q73306462 | ||
| Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays | Q74188063 | ||
| Changing the remodeling process in heart failure: basic mechanisms and laboratory results | Q74741190 | ||
| Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy | Q22254076 | ||
| Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein | Q22254242 | ||
| Actin mutations in dilated cardiomyopathy, a heritable form of heart failure | Q24310520 | ||
| Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere | Q24316399 | ||
| Many roads lead to a broken heart: the genetics of dilated cardiomyopathy | Q24535744 | ||
| A catalogue of genes in the cardiovascular system as identified by expressed sequence tags | Q24562782 | ||
| Basic local alignment search tool | Q25938991 | ||
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
| Genomic expression programs in the response of yeast cells to environmental changes | Q27860823 | ||
| Single pass sequencing of a unidirectional human fetal heart cDNA library to discover novel genes of the cardiovascular system | Q28235308 | ||
| Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy | Q28244969 | ||
| A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation | Q28258622 | ||
| Use of a cDNA microarray to analyse gene expression patterns in human cancer | Q29618814 | ||
| Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags | Q30650615 | ||
| Construction of a human cardiovascular cDNA microarray: portrait of the failing heart | Q30650689 | ||
| A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. | Q32161221 | ||
| Cardiac hypertrophy: sorting out the circuitry | Q33665828 | ||
| Controlling myocardial matrix remodeling: implications for heart failure. | Q33698043 | ||
| Stress pathways and heart failure | Q33734297 | ||
| Molecular regulation of phospholamban function and gene expression | Q33798507 | ||
| Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene | Q33872178 | ||
| A cardiovascular EST repertoire: progress and promise for understanding cardiovascular disease | Q33935449 | ||
| Cardiac intracellular calcium release channels: role in heart failure | Q33960297 | ||
| Genetic abnormalities responsible for dilated cardiomyopathy | Q34027566 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| dilated cardiomyopathy | Q283656 | ||
| P304 | page(s) | 2035-2043 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray | |
| P478 | volume | 160 |
| Q30983627 | A systematic review of large scale and heterogeneous gene array data in heart failure |
| Q36318553 | A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks |
| Q41466008 | Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure |
| Q28512007 | Ablation of the cardiac-specific gene leucine-rich repeat containing 10 (Lrrc10) results in dilated cardiomyopathy |
| Q30498939 | Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy |
| Q36063345 | Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and identified through conserved transcriptional responses in mice and humans |
| Q31043414 | Aetiology-specific patterns in end-stage heart failure patients identified by functional annotation and classification of microarray data |
| Q54567679 | Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. |
| Q47929312 | Altered expression of genes for Kir ion channels in dilated cardiomyopathy. |
| Q31160132 | Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies |
| Q42593572 | Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers |
| Q45205031 | Cardiac gene expression profile in rats with terminal heart failure and cachexia |
| Q35085050 | Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. |
| Q37296250 | Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue |
| Q47170506 | Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy |
| Q37408433 | Cardiovascular translational medicine (III). Genomics and proteomics in heart failure research |
| Q57912008 | Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP form |
| Q35732935 | Cleavage of serum response factor mediated by enteroviral protease 2A contributes to impaired cardiac function |
| Q54378689 | Comparative analysis of oncofetal fibronectin and tenascin-C expression in right atrial auricular and left ventricular human cardiac tissue from patients with coronary artery disease and aortic valve stenosis. |
| Q35756255 | Computational physiology and the Physiome Project |
| Q34557154 | DOT1L regulates dystrophin expression and is critical for cardiac function |
| Q42603701 | Differential myocardial gene expression in the development and rescue of murine heart failure |
| Q33211643 | Distinct molecular portraits of human failing hearts identified by dedicated cDNA microarrays |
| Q34652525 | Earliest changes in the left ventricular transcriptome postmyocardial infarction |
| Q57923269 | Effect of changes in action potential spike configuration, junctional sarcoplasmic reticulum micro-architecture and altered t-tubule structure in human heart failure |
| Q38316768 | Expression profiling of a hypercontraction-induced myopathy in Drosophila suggests a compensatory cytoskeletal remodeling response. |
| Q35978591 | Expression profiling of cardiovascular disease |
| Q47284005 | Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes |
| Q38341556 | Gene expression profiling in peripheral blood nuclear cells in patients with refractory ischaemic end-stage heart failure. |
| Q35758712 | Gene expression profiling: from microarrays to medicine. |
| Q79895265 | Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium |
| Q34049499 | Genome informatics: current status and future prospects |
| Q37656076 | Genomics of cardiovascular disease |
| Q34314129 | Genomics, proteomics and bioinformatics of human heart failure |
| Q38521995 | Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. |
| Q42683876 | Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradation |
| Q36763260 | Hierarchical approaches for systems modeling in cardiac development. |
| Q33321366 | Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences |
| Q36748674 | Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy |
| Q33454995 | Identification of gene co-regulatory modules and associated cis-elements involved in degenerative heart disease |
| Q34571329 | Identification of temporal and region-specific myocardial gene expression patterns in response to infarction in swine. |
| Q42329742 | Identification of the molecular mechanisms underlying dilated cardiomyopathy via bioinformatic analysis of gene expression profiles |
| Q37089986 | Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. |
| Q33983069 | Inositol trisphosphate receptor Ca2+ release channels. |
| Q38267844 | Insights into RNA transcriptome profiling of cardiac tissue in obesity and hypertension conditions |
| Q36154933 | Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy |
| Q57395343 | La genómica y la proteómica en la investigación de la insuficiencia cardiaca |
| Q83821167 | Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE |
| Q34124934 | Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy |
| Q82014544 | Marked differences between atrial and ventricular gene-expression remodeling in dogs with experimental heart failure |
| Q37575967 | Mena associates with Rac1 and modulates connexin 43 remodeling in cardiomyocytes |
| Q38291714 | Methylome analysis reveals alterations in DNA methylation in the regulatory regions of left ventricle development genes in human dilated cardiomyopathy |
| Q35128069 | Microarray analysis: a novel research tool for cardiovascular scientists and physicians. |
| Q92816390 | Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells |
| Q35936390 | Molecular genetics and genomics of heart failure |
| Q37702396 | Molecular mechanisms in evolutionary cardiology failure |
| Q28566976 | Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility |
| Q40377138 | Molecular signature analysis: the potential of gene-expression analysis in cardiomyopathy |
| Q38037357 | Molecular signatures and the study of gene expression profiles in inflammatory heart diseases |
| Q54732045 | Myocardial hypertrophy is not a prerequisite for changes in early gene expression in left ventricular volume overload. |
| Q37382176 | Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome |
| Q36593277 | Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies |
| Q36761037 | Novel proteins associated with human dilated cardiomyopathy: selective reduction in α(1A)-adrenergic receptors and increased desensitization proteins |
| Q37189947 | PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart |
| Q36898747 | Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine |
| Q33471552 | Proteomic analysis reveals significant elevation of heat shock protein 70 in patients with chronic heart failure due to arrhythmogenic right ventricular cardiomyopathy |
| Q39404378 | Proteostasis in cardiac health and disease. |
| Q48293271 | Putative functional genes in idiopathic dilated cardiomyopathy |
| Q35226477 | Questions and answers on design of dual-label microarrays for identifying differentially expressed genes |
| Q34172616 | Recent progress in histochemistry and cell biology |
| Q91885085 | Reduced hybrid/complex N-glycosylation disrupts cardiac electrical signaling and calcium handling in a model of dilated cardiomyopathy |
| Q57124944 | Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy |
| Q54578401 | Reorganized PKA-AKAP associations in the failing human heart. |
| Q37258938 | Serial gene expression profiling in the intact human heart |
| Q34808395 | Sex- and age-dependent human transcriptome variability: implications for chronic heart failure |
| Q35095401 | Targeting signaling pathways in heart failure by gene transfer |
| Q34724819 | The 'thousand-dollar genome': an ethical exploration |
| Q26740620 | The Role of Leucine-Rich Repeat Containing Protein 10 (LRRC10) in Dilated Cardiomyopathy |
| Q36239248 | The histone 3 lysine 9 methyltransferase inhibitor chaetocin improves prognosis in a rat model of high salt diet-induced heart failure |
| Q52112465 | Transcriptomal analysis of failing and nonfailing human hearts. |
| Q38652049 | Transcriptome Profiling in Human Diseases: New Advances and Perspectives |
| Q37448085 | Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks |
Search more.